Active Ingredient(s): Deferasirox
FDA Approved: * November 2, 2005
Pharm Company: * NOVARTIS
Category: Iron Chelator

Deferasirox, sold under the brand name Exjade & Asunra (in injectable form) & Oleptiss (Tablet formulation) both by Novartis among others, is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.[2][3] It is the first oral medication approved in the United States for this purpose.[4] It was appro... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
4 Discussions

Dosage List

Exjade J;250;NVR
Exjade 2.5 mg/ml Oral Suspension
NDC: 0078-0469
Novartis Pharmaceuticals Corporation
Exjade J;500;NVR
Exjade 5 mg/ml Oral Suspension
NDC: 0078-0470
Novartis Pharmaceuticals Corporation
Exjade 1.25 mg/ml Oral Suspension
NDC: 0078-0468
Novartis Pharmaceuticals Corporation

Related Brands

Drugs with the same active ingredients

Popular Topics

Exjade and diarrhea

I have been taking Exjade at a daily rate of 2250 mg. I also have blood transfusions every two weeks. Of late I get chro...

exjade j code

What code could be used for Exjade if billed to a major medical plan?...